Lunit will deploy its INSIGHT MMG AI mammography solution across three Stockholm Region hospitals, supporting an expected 200,000 – 250,000 examinations annually.
Imagion Biosystems has extended its collaboration with Siemens Healthineers to support the Phase 2 clinical trial of the MagSense imaging agent for HER2-positive breast cancer.
Researchers have found that AI-derived breast cancer risk scores from screening mammograms change over time in women who develop breast cancer while remaining stable in cancer-free women.
German MedTech firm installs its nu:view spiral breast CT at Malvern Breast Imaging, bringing compression-free 3D breast imaging to Australia for the first time.
DeepHealth has launched the Breast Suite, a modular AI-powered platform designed to support breast cancer detection, risk stratification, and diagnostic workflow efficiency.
A major study presented at the RSNA reveals that invasive breast cancer is more common in younger women than previously assumed, underscoring the need to revisit current screening and risk-assessment strategies.
Gnosis for Her has unveiled a mobile breast care unit featuring an FDA-cleared 3D breast CT system that provides high-resolution imaging without compression, improving comfort and accessibility for women’s breast diagnostics.
A new AI-powered software analyzes mammograms to predict a woman's personalized five-year risk of developing breast cancer, earning the FDA’s Breakthrough Device designation.
This website uses cookies to give our readers the best website experience. Please refer to our privacy policy to find out how we use cookies and how you can edit your preferences.